Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Mar. Drugs 2009, 7(4), 833-849; doi:10.3390/md7040833

Terpenyl-Purines from the Sea

Received: 12 November 2009; in revised form: 26 November 2009 / Accepted: 22 December 2009 / Published: 23 December 2009
(This article belongs to the Special Issue Alkaloid Analogs)
View Full-Text   |   Download PDF [175 KB, uploaded 23 December 2009]   |   Browse Figures
Abstract: Agelasines, asmarines and related compounds are natural products with a hybrid terpene-purine structure isolated from numerous genera of sponges (Agela sp., Raspailia sp.). Some agelasine analogs and related structures have displayed high general toxicity towards protozoa, and have exhibited broad-spectrum antimicrobial activity against a variety of species, including Mycobacterium tuberculosis, and also an important cytotoxic activity against several cancer cell lines, including multidrug-resistant ones. Of particular interest in this context are the asmarines (tetrahydro[1,4]diazepino[1,2,3-g,h]purines), which have shown potent antiproliferative activity against several types of human cancer cell lines. This review summarizes the sources of isolation, chemistry and bioactivity of marine alkylpurines and their bioactive derivatives.
Keywords: agelasine; agelasimine; ageline; asmarine; alkyl-purine; terpene-purine; terpenylpurine agelasine; agelasimine; ageline; asmarine; alkyl-purine; terpene-purine; terpenylpurine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Gordaliza, M. Terpenyl-Purines from the Sea. Mar. Drugs 2009, 7, 833-849.

AMA Style

Gordaliza M. Terpenyl-Purines from the Sea. Marine Drugs. 2009; 7(4):833-849.

Chicago/Turabian Style

Gordaliza, Marina. 2009. "Terpenyl-Purines from the Sea." Mar. Drugs 7, no. 4: 833-849.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert